How Expert Medical Writing Accelerates Your Path to First-in-Human Trials
An Investigator’s Brochure (IB) is a critical document that communicates the available nonclinical and clinical data for an investigational product, helping investigators understand its rationale, risks, and potential benefits. As development programs evolve, keeping the IB accurate, compliant, and aligned with regulatory expectations can become increasingly complex.
This practical guide provides an overview of the IB lifecycle, key update considerations, source documents, review processes, and common challenges encountered during development. Whether you are preparing your first IB or managing ongoing annual updates, this guide offers insights to support a structured and efficient approach.
Download the full guide to explore best practices, practical tips, and strategies for developing and maintaining high-quality Investigator’s Brochures.
IND to IMPD Adaptation to Open Sites in Europe
Morula Health supported a repeat US biotech client with medical writing for an FDA Type B meeting. By delivering clear, submission‑ready documentation, our team helped the client engage regulators with confidence and maintain program momentum.
Find out more
Redefining Therapeutic Potential: Large Oncology IND Submission
Morula Health supported a UK biotech with the delivery and management of a large oncology IND submission. Our regulatory medical writing expertise ensured consistency across complex documentation and supported a successful regulatory outcome.
Find out more
Breaking Barriers: Facilitating FDA Approval
Morula Health developed a first‑in‑human Phase 1 protocol for an FDA IND submission within five weeks. By combining regulatory insight with immuno‑oncology expertise, our team helped the client meet critical timelines and advance their program toward approval.
Find out more